ASND — Ascendis Pharma A/S Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

Annual cashflow statement for Ascendis Pharma A/S, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-218	-419	-384	-583	-481
Depreciation
Amortisation
Non-Cash Items	22.3	138	-2.56	89.2	124
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	13.1	-0.047	-46.9	-19.6	-129
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-176	-272	-418	-496	-467
Capital Expenditures	-5.16	-21.6	-24.2	-14.5	-2.44
Purchase of Fixed Assets
Software Development Costs
Other Investing Cash Flow Items	—	-270	-86.3	76.2	289
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities	-5.16	-291	-111	61.7	286
Financing Cash Flow Items	-31.7	-31.4	—	—	-1.81
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	494	603	351	397	134
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	320	-13.6	-138	-1.5	-52.6